January 6, 2017: Depomed Inc said to have received one bid according to reports in the mainstream financial media. Recent mainstream media commentary on potential sale of Depomed:
– On Dec 31st KKR remains interested in acquiring Depomed – NY Post
– One analyst cited expects a deal would value DEPO at $25/shr or $1.5 (Read More….)
A weekly Saturday night show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators.
This week’s show features Trump’s comments about bringing down drug prices, the incredible trial results from Bellicum Pharmaceuticals that cured all 35 children in the trial, takeover rumors surrounding (Read More….)